Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrons | 9 | 2025 | 17 | 1.260 |
Why?
|
| Cognition | 9 | 2019 | 473 | 1.140 |
Why?
|
| Mental Disorders | 5 | 2025 | 392 | 1.130 |
Why?
|
| Silicon | 3 | 2021 | 17 | 1.030 |
Why?
|
| Avoidance Learning | 2 | 2025 | 70 | 1.010 |
Why?
|
| Self Concept | 5 | 2010 | 171 | 0.900 |
Why?
|
| Radiation Monitoring | 4 | 2024 | 9 | 0.890 |
Why?
|
| Self Disclosure | 2 | 2018 | 44 | 0.880 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2024 | 300 | 0.860 |
Why?
|
| Body Image | 5 | 2018 | 89 | 0.820 |
Why?
|
| Students | 5 | 2020 | 626 | 0.750 |
Why?
|
| Eating | 4 | 2012 | 167 | 0.690 |
Why?
|
| Stress, Psychological | 4 | 2010 | 661 | 0.630 |
Why?
|
| Psychotherapy | 3 | 2022 | 59 | 0.610 |
Why?
|
| Boron Neutron Capture Therapy | 3 | 2025 | 3 | 0.570 |
Why?
|
| Cognition Disorders | 2 | 2010 | 243 | 0.540 |
Why?
|
| Depression | 2 | 2024 | 863 | 0.530 |
Why?
|
| Thinking | 4 | 2010 | 37 | 0.520 |
Why?
|
| Neurons | 1 | 2024 | 1263 | 0.500 |
Why?
|
| Attitude to Health | 3 | 2011 | 338 | 0.490 |
Why?
|
| Humans | 43 | 2026 | 43102 | 0.480 |
Why?
|
| Anxiety | 3 | 2020 | 874 | 0.480 |
Why?
|
| Adolescent | 17 | 2019 | 6081 | 0.470 |
Why?
|
| Quality of Life | 3 | 2011 | 616 | 0.460 |
Why?
|
| Behavior Therapy | 3 | 2008 | 180 | 0.460 |
Why?
|
| Adult | 21 | 2026 | 13872 | 0.450 |
Why?
|
| Monte Carlo Method | 4 | 2024 | 64 | 0.450 |
Why?
|
| Glass | 3 | 2025 | 19 | 0.420 |
Why?
|
| Female | 29 | 2026 | 24698 | 0.420 |
Why?
|
| Lithium | 3 | 2025 | 31 | 0.410 |
Why?
|
| Scintillation Counting | 2 | 2025 | 4 | 0.400 |
Why?
|
| Young Adult | 13 | 2025 | 5080 | 0.400 |
Why?
|
| Radiation Dosage | 2 | 2024 | 37 | 0.390 |
Why?
|
| Psychology, Social | 1 | 2012 | 5 | 0.390 |
Why?
|
| Radiometry | 4 | 2024 | 8 | 0.380 |
Why?
|
| Phobic Disorders | 4 | 2013 | 25 | 0.370 |
Why?
|
| Pediatrics | 1 | 2012 | 70 | 0.370 |
Why?
|
| Male | 23 | 2026 | 23409 | 0.360 |
Why?
|
| Mental Health | 3 | 2010 | 385 | 0.340 |
Why?
|
| Optical Fibers | 2 | 2025 | 8 | 0.320 |
Why?
|
| Feeding Behavior | 2 | 2012 | 469 | 0.320 |
Why?
|
| Parents | 3 | 2014 | 370 | 0.320 |
Why?
|
| Cross-Sectional Studies | 8 | 2020 | 3156 | 0.310 |
Why?
|
| Computer Simulation | 2 | 2024 | 408 | 0.300 |
Why?
|
| Resilience, Psychological | 1 | 2011 | 106 | 0.300 |
Why?
|
| Equipment Design | 4 | 2024 | 145 | 0.290 |
Why?
|
| Affective Symptoms | 1 | 2009 | 63 | 0.290 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 187 | 0.290 |
Why?
|
| Culture | 1 | 2009 | 172 | 0.280 |
Why?
|
| Middle Aged | 14 | 2026 | 12222 | 0.280 |
Why?
|
| Attitude | 1 | 2009 | 108 | 0.280 |
Why?
|
| Universities | 4 | 2020 | 559 | 0.270 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 161 | 0.250 |
Why?
|
| Yoga | 2 | 2018 | 33 | 0.250 |
Why?
|
| Prejudice | 1 | 2007 | 116 | 0.250 |
Why?
|
| Peer Group | 2 | 2012 | 177 | 0.250 |
Why?
|
| Phantoms, Imaging | 2 | 2025 | 28 | 0.250 |
Why?
|
| Volition | 1 | 2006 | 9 | 0.240 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2006 | 25 | 0.240 |
Why?
|
| X-Ray Microtomography | 1 | 2025 | 22 | 0.240 |
Why?
|
| Self-Injurious Behavior | 1 | 2005 | 25 | 0.230 |
Why?
|
| Treatment Outcome | 8 | 2026 | 1604 | 0.230 |
Why?
|
| Cerium | 1 | 2025 | 18 | 0.230 |
Why?
|
| Cocaine-Related Disorders | 1 | 2026 | 102 | 0.230 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2025 | 94 | 0.220 |
Why?
|
| Quality Assurance, Health Care | 1 | 2025 | 55 | 0.220 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2012 | 282 | 0.220 |
Why?
|
| Skin | 1 | 2005 | 187 | 0.220 |
Why?
|
| Chick Embryo | 1 | 2024 | 79 | 0.210 |
Why?
|
| Patient Compliance | 1 | 2006 | 233 | 0.210 |
Why?
|
| Health Education | 1 | 2007 | 363 | 0.210 |
Why?
|
| Mental Recall | 1 | 2004 | 84 | 0.210 |
Why?
|
| Axons | 1 | 2024 | 117 | 0.200 |
Why?
|
| Adaptation, Psychological | 3 | 2011 | 420 | 0.200 |
Why?
|
| Gene Regulatory Networks | 1 | 2024 | 149 | 0.200 |
Why?
|
| Gamma Rays | 4 | 2021 | 27 | 0.190 |
Why?
|
| Professional-Patient Relations | 1 | 2022 | 60 | 0.180 |
Why?
|
| Focus Groups | 1 | 2024 | 423 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2024 | 386 | 0.180 |
Why?
|
| Sutures | 1 | 2021 | 2 | 0.170 |
Why?
|
| Suture Techniques | 1 | 2021 | 10 | 0.170 |
Why?
|
| Orthopedics | 1 | 2021 | 8 | 0.170 |
Why?
|
| Tensile Strength | 1 | 2021 | 27 | 0.170 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 33 | 0.170 |
Why?
|
| Isotopes | 1 | 2020 | 9 | 0.160 |
Why?
|
| Obesity | 1 | 2009 | 1151 | 0.160 |
Why?
|
| Fear | 3 | 2019 | 272 | 0.160 |
Why?
|
| Awareness | 2 | 2012 | 73 | 0.150 |
Why?
|
| Speech | 1 | 2019 | 16 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2024 | 735 | 0.150 |
Why?
|
| Students, Medical | 1 | 2021 | 158 | 0.140 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2002 | 298 | 0.140 |
Why?
|
| Viral Core Proteins | 1 | 2018 | 12 | 0.140 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2018 | 14 | 0.140 |
Why?
|
| Histone Acetyltransferases | 1 | 2018 | 21 | 0.140 |
Why?
|
| Oogenesis | 1 | 2018 | 29 | 0.140 |
Why?
|
| Arthralgia | 1 | 2018 | 12 | 0.140 |
Why?
|
| Influenza A virus | 1 | 2018 | 31 | 0.140 |
Why?
|
| Ovarian Follicle | 1 | 2018 | 44 | 0.140 |
Why?
|
| Embryonic Development | 1 | 2018 | 83 | 0.130 |
Why?
|
| Hawaii | 1 | 2024 | 2011 | 0.130 |
Why?
|
| Emotions | 2 | 2010 | 254 | 0.130 |
Why?
|
| Models, Psychological | 2 | 2009 | 140 | 0.130 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 24 | 0.130 |
Why?
|
| Phytotherapy | 1 | 2017 | 75 | 0.120 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 136 | 0.120 |
Why?
|
| Meditation | 2 | 2016 | 25 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2017 | 92 | 0.120 |
Why?
|
| Radiotherapy Dosage | 3 | 2025 | 8 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2011 | 549 | 0.110 |
Why?
|
| Mice | 2 | 2024 | 6644 | 0.110 |
Why?
|
| Attention | 2 | 2010 | 174 | 0.110 |
Why?
|
| Anxiety Disorders | 2 | 2016 | 322 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2017 | 195 | 0.110 |
Why?
|
| Psychometrics | 2 | 2007 | 358 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2017 | 302 | 0.100 |
Why?
|
| Psychological Tests | 2 | 2012 | 56 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2013 | 123 | 0.100 |
Why?
|
| Parent-Child Relations | 1 | 2014 | 127 | 0.100 |
Why?
|
| Implosive Therapy | 1 | 2012 | 14 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 2012 | 74 | 0.090 |
Why?
|
| Methadone | 1 | 2012 | 24 | 0.090 |
Why?
|
| Narcotics | 1 | 2012 | 29 | 0.090 |
Why?
|
| Animals | 4 | 2024 | 16992 | 0.090 |
Why?
|
| Miniaturization | 1 | 2011 | 5 | 0.090 |
Why?
|
| Plastics | 1 | 2011 | 14 | 0.090 |
Why?
|
| Research Design | 1 | 2013 | 385 | 0.090 |
Why?
|
| Family | 1 | 2012 | 195 | 0.090 |
Why?
|
| Photons | 1 | 2010 | 29 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 211 | 0.080 |
Why?
|
| Schools | 1 | 2012 | 283 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2011 | 91 | 0.080 |
Why?
|
| Radiation Protection | 2 | 2024 | 5 | 0.080 |
Why?
|
| Counseling | 2 | 2026 | 138 | 0.080 |
Why?
|
| Verbal Behavior | 1 | 2008 | 12 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2013 | 925 | 0.070 |
Why?
|
| Education | 1 | 2009 | 60 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2012 | 195 | 0.070 |
Why?
|
| Organoplatinum Compounds | 1 | 2008 | 19 | 0.070 |
Why?
|
| Pain | 1 | 2011 | 290 | 0.070 |
Why?
|
| Body Water | 1 | 2008 | 26 | 0.070 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 222 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 575 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2008 | 172 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 830 | 0.060 |
Why?
|
| Kidney | 1 | 2008 | 372 | 0.060 |
Why?
|
| Quality Control | 1 | 2025 | 42 | 0.060 |
Why?
|
| Persuasive Communication | 1 | 2004 | 9 | 0.050 |
Why?
|
| Japan | 1 | 2024 | 348 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 1067 | 0.050 |
Why?
|
| Task Performance and Analysis | 1 | 2002 | 47 | 0.040 |
Why?
|
| Americium | 1 | 2020 | 1 | 0.040 |
Why?
|
| Californium | 1 | 2020 | 2 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 1081 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 1019 | 0.040 |
Why?
|
| Conditioning, Operant | 1 | 2019 | 90 | 0.040 |
Why?
|
| Reward | 1 | 2019 | 112 | 0.040 |
Why?
|
| Nucleocapsid Proteins | 1 | 2018 | 12 | 0.040 |
Why?
|
| Motivation | 1 | 2022 | 513 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2018 | 82 | 0.030 |
Why?
|
| Acetylation | 1 | 2018 | 107 | 0.030 |
Why?
|
| Oocytes | 1 | 2018 | 149 | 0.030 |
Why?
|
| Lysine | 1 | 2018 | 119 | 0.030 |
Why?
|
| Myanmar | 1 | 2017 | 2 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2002 | 1546 | 0.030 |
Why?
|
| Plant Stems | 1 | 2017 | 12 | 0.030 |
Why?
|
| Medicine, Traditional | 1 | 2017 | 23 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 247 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 690 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 182 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 185 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2018 | 321 | 0.030 |
Why?
|
| Dogs | 1 | 2017 | 204 | 0.030 |
Why?
|
| Aged | 3 | 2013 | 8214 | 0.030 |
Why?
|
| Time Factors | 2 | 2012 | 1857 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2018 | 883 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 241 | 0.030 |
Why?
|
| Virus Replication | 1 | 2018 | 318 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 1180 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 291 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 592 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 1035 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2018 | 434 | 0.030 |
Why?
|
| Child | 2 | 2013 | 3443 | 0.030 |
Why?
|
| Uridine | 1 | 2013 | 7 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1271 | 0.030 |
Why?
|
| Boron | 1 | 2013 | 10 | 0.020 |
Why?
|
| Calibration | 1 | 2013 | 63 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 1410 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 1869 | 0.020 |
Why?
|
| Psychotherapy, Group | 1 | 2012 | 23 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 45 | 0.020 |
Why?
|
| Substance Abuse Detection | 1 | 2012 | 31 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2012 | 32 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 116 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 405 | 0.020 |
Why?
|
| Iodides | 1 | 2011 | 5 | 0.020 |
Why?
|
| Cesium | 1 | 2011 | 8 | 0.020 |
Why?
|
| United States | 1 | 2022 | 5205 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2010 | 17 | 0.020 |
Why?
|
| Luminescence | 1 | 2010 | 31 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2012 | 126 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 139 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 259 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 760 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 719 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2012 | 457 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 2008 | 18 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 32 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 67 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2008 | 29 | 0.020 |
Why?
|
| Drinking | 1 | 2008 | 37 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2008 | 39 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 1234 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2012 | 497 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 429 | 0.020 |
Why?
|
| Longevity | 1 | 2008 | 173 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1124 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 375 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 3735 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1568 | 0.010 |
Why?
|